US Stock MarketDetailed Quotes

Genmab (GMAB)

Watchlist
  • 26.540
  • -0.360-1.34%
Close May 15 16:00 ET
  • 26.540
  • 0.0000.00%
Post 20:01 ET
17.05BMarket Cap20.18P/E (TTM)

Genmab (GMAB) Revenue Breakdown Overview

By Business/Source

Currency:USD
2026/Q1
Stock NameRevenueRatio
DARZALEX562M62.72%
Net product sales116M12.95%
Kesimpta116M12.95%
Other38M4.24%
TEPEZZA26M2.90%
Milestone revenue16M1.79%
Collaboration revenue14M1.56%
Reimbursement revenue8M0.89%
View all

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
Denmark3.33B89.41%
Japan213M5.73%
United States180M4.84%
Netherlands1M0.03%
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More